L&C Bio Co., Ltd (290650.KQ)

KRW 22600.0

(1.8%)

Total Debt Summary of L&C Bio Co., Ltd

L&C Bio Co., Ltd's latest annual total debt in 2023 was 82.13 Billion KRW , up 0.23% from previous year.
L&C Bio Co., Ltd's latest quarterly total debt in 2024 Q2 was 81.9 Billion KRW , up 1.12% from previous quarter.
L&C Bio Co., Ltd reported annual total debt of 81.94 Billion KRW in 2022, up 1099.6% from previous year.
L&C Bio Co., Ltd reported annual total debt of 6.83 Billion KRW in 2021, down -54.56% from previous year.
L&C Bio Co., Ltd reported quarterly total debt of 80.99 Billion KRW for 2024 Q1, down -1.38% from previous quarter.
L&C Bio Co., Ltd reported quarterly total debt of 87.02 Billion KRW for 2023 Q2, up 4.66% from previous quarter.

Annual Total Debt Chart of L&C Bio Co., Ltd (2023 - 2015)

Historical Annual Total Debt of L&C Bio Co., Ltd (2023 - 2015)

Year	Total Debt	Total Debt Growth
2023	82.13 Billion KRW	0.23%
2022	81.94 Billion KRW	1099.6%
2021	6.83 Billion KRW	-54.56%
2020	15.03 Billion KRW	739.14%
2019	1.79 Billion KRW	79.15%
2018	1 Billion KRW	116.22%
2017	462.5 Million KRW	-50.95%
2016	942.84 Million KRW	-48.95%
2015	1.84 Billion KRW	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	81.9 Billion KRW	1.12%
2024 Q1	80.99 Billion KRW	-1.38%
2023 Q2	87.02 Billion KRW	4.66%
2023 Q4	82.13 Billion KRW	1.8%
2023 FY	82.13 Billion KRW	0.23%
2023 Q1	83.15 Billion KRW	1.47%
2023 Q3	80.68 Billion KRW	-7.29%
2022 FY	81.94 Billion KRW	1099.6%
2022 Q4	81.94 Billion KRW	13.64%
2022 Q3	72.1 Billion KRW	9.68%
2022 Q2	65.74 Billion KRW	1019.66%
2022 Q1	5.87 Billion KRW	-14.04%
2021 Q1	14.15 Billion KRW	-5.86%
2021 Q4	6.83 Billion KRW	314.0%
2021 Q3	1.65 Billion KRW	13.79%
2021 Q2	1.45 Billion KRW	-89.75%
2021 FY	6.83 Billion KRW	-54.56%
2020 FY	15.03 Billion KRW	739.14%
2020 Q3	13.71 Billion KRW	1.58%
2020 Q4	15.03 Billion KRW	9.57%
2020 Q2	13.5 Billion KRW	-10.87%
2020 Q1	15.15 Billion KRW	745.87%
2019 Q3	1 Billion KRW	0.0%
2019 Q4	1.79 Billion KRW	79.15%
2019 FY	1.79 Billion KRW	79.15%
2019 Q2	1 Billion KRW	0.0%
2019 Q1	1 Billion KRW	0.0%
2018 Q2	1.2 Billion KRW	0.0%
2018 FY	1 Billion KRW	116.22%
2018 Q4	1 Billion KRW	0.0%
2017 Q4	462.5 Million KRW	0.0%
2017 FY	462.5 Million KRW	-50.95%
2016 FY	942.84 Million KRW	-48.95%
2015 FY	1.84 Billion KRW	0.0%

Peer Total Debt Comparison of L&C Bio Co., Ltd

Name	Total Debt	Total Debt Difference
Osang Healthcare Co.,Ltd	697.79 Million KRW	-11670.531%
InBody Co.,Ltd	6.08 Billion KRW	-1250.826%
Curexo Inc.	2.05 Billion KRW	-3888.326%
Seegene, Inc.	141.76 Billion KRW	42.063%
i-SENS, Inc.	143.79 Billion KRW	42.879%
Ray Co., Ltd.	86.67 Billion KRW	5.243%
Gencurix Inc.	17.95 Billion KRW	-357.447%
Sugentech Inc.	15.3 Billion KRW	-436.699%